Elena Castro explains the biological features of prostate cancer, the impact of heterogeneity in prostate cancer and its management, the role for genomic sequencing in identifying patients with prostate cancer whose tumour exhibit actionable targets, the impact of genetic and genomic advances for the treatment of patients with prostate cancer, and how to accelerate precision medicine approaches in patients with prostate cancer.
Produced by the European Society for Medical Oncology
www.esmo.org